South Korea's healthcare system is characterized by a rapid transition toward "Smart Health." With an aging population and a rising incidence of type 2 diabetes in urban centers like Seoul and Busan, there is an urgent demand for a continous glucose monitor that fits the fast-paced lifestyle of the Korean workforce.
The local market is highly sensitive to device miniaturization and connectivity. Korean patients prefer integrated ecosystems where their glucose monitor patch can sync instantly with smartphones and cloud-based hospital records, reducing the need for frequent clinic visits.
Furthermore, the stringent regulatory environment of the MFDS (Ministry of Food and Drug Safety) ensures that only high-E-E-A-T compliant devices enter the market, pushing manufacturers to prioritize clinical validation and bio-compatibility in their sensor materials.
